Tuesday, 31 March, 2026
Tata 1mg Seeks $200 Million Funding Amid Valuation Dispute
By Isha
Tata 1mg, the online pharmacy arm of Tata Digital, is aiming to raise up to $200 million to fuel its next growth phase. Investors including Novo Holdings, CPPIB, Permira, and ChrysCapital have shown interest. However, they dispute the 2022 valuation of $1.25 billion, proposing a range of $750–800 million instead. Some investors also seek board seats, which Tata is unwilling to grant.
Read full story at Economic Times